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Abstract
Cancer cells, including leukemia cells, reside in a complex microenvironment, which 
influences biology and activity of the cells. The protective role of bone marrow stromal 
cells is already commonly recognized. Remodeling of stroma cell functions by leukemia 
cells is also well documented. In this respect, different routes of interactions were defined, 
such as direct cell-cell interactions or indirect cross talk, by release of soluble factors or 
vesicular particles containing proteins, RNAs and other molecules. Since intercellular 
communication seems to play a role in various biological processes, it might be impor-
tant to conduct studies in co-culture systems, which at least mimic partially more physi-
ological conditions, and enables this intercellular exchange to occur. Thus, it is crucial to 
improve analytical methods of investigation of co-cultured cells, to study their interac-
tions and so to understand biology of leukemia in order to understand molecular mecha-
nisms and offer novel therapeutic strategies. The present chapter outlines the importance 
of modern, multiparameter flow cytometry methods, which allow to analyze interactions 
between different types of cells within the leukemia microenvironment. Importantly, the 
proposed experimental setups can be easily transformed to study different cell types and 
different biological systems.
Keywords: co-culture, cell-cell interactions, cell tracking, tracking dyes, proliferation 
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1. Introduction
Cancer cells, including leukemia cells, reside in a microenvironment, which influences biol-
ogy and activity of these cells. The importance of microenvironment in leukemia cells biology 
is widely accepted. Leukemia microenvironment is a complex and dynamic network, com-
prising different types of cells [1]. There is a direct and indirect cross talk between these cells, 
which modulates cell function, signal transduction and response to therapy. This intercellular 
interactions can contribute to leukemogenesis [2]. Thus, unraveling of interplay between all 
types of cells and the microenvironment is crucial for understanding the biology of leukemia.
Because of its key regulatory role, the cross talk between leukemia and bystander cells is of 
interest as possible therapeutic target [3]. It is critically important to take such cell-cell interac-
tions into account in the studies of potential therapeutic strategies, novel therapeutic targets 
and novel treatment regimes. To partially mimic the physiological conditions, an increasing 
number of the basic research as well as preclinical studies in the cancer biology area use the in 
vitro cell co-culture systems, in which two or more types of cells are cultured together [4]. This 
allows natural interactions to occur between different types of cells, which normally coexist 
within the microenvironment.
Therefore, it becomes crucial to improve analytical methods of investigation of co-cultured cells 
to study their interactions and so to understand biology of leukemia in order to offer novel ther-
apeutic strategies. The principle of flow cytometry is separation of cells/events based on their 
fluorescence signals. Using different types of cell tracking techniques, combined with mod-
ern, multiparameter flow cytometry methods, it has become possible to analyze interactions 
between different types of cells within the leukemia microenvironment. Flow cytometry allows 
for gating cells of interest from the whole cell mixture based on the fluorescence parameter to 
study different cell features, cellular processes and signaling in separated subpopulations.
2. Bone marrow niche in leukemia
The concept of “niche” has been introduced in 1978 by Schofield to describe the possibil-
ity of association of hematopoietic stem cell (HSC) with its surroundings that regulates and 
determines HSC fate, such as self-renewal, differentiation, proliferation and survival [5]. Since 
then, many evidences appeared showing its composition and function. The bone marrow 
microenvironment (BMM) is complex and consists of the extracellular matrix and multiple 
cell populations, including different types of endothelial cells, osteolineage cells, osteoclasts, 
adipocytes, sympathetic neurons, non-myelinating Schwann cells, mesenchymal cells and 
macrophages [1, 6]. Interactions between leukemia cells and their niche are bi-directional. 
They represent either direct interactions by cell-cell contact or indirect interactions by secreted 
soluble factors and extracellular vesicles.
Over the years, our understanding of the BMM role in leukemogenesis has greatly increased. 
Bone marrow microenvironment supports proleukemic features of cells. Regulation of leuke-
mia stem/progenitor cells (LS/PC) strongly depends on the signals from the bone marrow micro-
environment [3, 7]. They promote leukemia progression as well as development of resistance 
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to therapy. Bone marrow microenvironment is a key player in the pathogenesis and leukemia 
development by creating conditions which promote survival and proliferation of leukemic 
blasts [8].
There are many evidence confirming protective role of the bone marrow stroma. Several 
mechanisms leading to chemoresistance in leukemia cells mediated by BMM have been 
described. Among these, stroma fibroblasts represent one of the main population within the 
bone marrow niche, strongly supporting leukemogenesis. Interaction of leukemia cells with 
stroma fibroblasts results in the increased resistance to cell death in response to drug treat-
ment, changes in metabolism and decreased clonogenic potential [9, 10]. Leukemia cells can 
also shape the bone marrow microenvironment. We have observed that leukemia cells par-
ticipate in the remodeling of stroma extracellular matrix [11]. Due to secretion of stroma-
modifying enzymes, leukemia cells support disarrangement in the leukemic bone marrow. 
Another aspect of the leukemia microenvironment is development and promotion of the 
inflammatory microenvironment [12, 13]. Activation of intrinsic factors like NF-κB as well 
as extrinsic components including cytokines, chemokines and adhesion molecules leads to 
complex responses promoting proinflammatory state. In general, this supports the process of 
transformation, survival and proliferation of leukemia cells.
Altogether, due to their importance and key role, targeting the leukemia-stroma interac-
tions has gained big interest as a novel and attractive strategy for anti-leukemia treatment. 
Currently, our understanding of the function and importance of the bone marrow niche in 
hematological neoplasms has increased due to improved murine models and development 
of imaging tools [14–16]. Nevertheless, the in vitro studies are still necessary to investigate 
mechanisms and signaling between leukemia and stromal cells as well as a proof of concept 
experiments in the drug designing and testing of novel therapeutic strategies.
Our group is involved in the studies of leukemia-stroma interactions and remodeling of 
stroma cell functions mediated by leukemia cells. We have used experimental setups to inves-
tigate leukemia cells in vitro, either cell lines or primary cells from patients, in the conditions 
mimicking the bone marrow millieu, thus hypoxia and co-culture with stroma fibroblasts. 
Herein we present and discuss some of the experimental systems utilized to study the role of 
the cross talk between leukemia and stromal cells to which multiparameter flow cytometry 
can be adapted. Importantly, these experimental approaches can be transferred to other cell 
types and different biological systems.
3. Fluorescent cell tracking to follow cell type, function, and state in 
co-cultures
Upon co-culture conditions, when different types of cells are cultured together, the key com-
ponent of the experimental strategy enabling cell analysis is to separate both cell types, either 
physically by sorting or by flow cytometry gating. For this, cells have to express some fluo-
rescent protein or have to be stained and tracked by fluorescent dye. This allows to separate 
signals from each type of cell based on the different fluorochromes using flow cytometry. The 
scheme and typical histograms to analyze tracked cells in co-culture are presented in Figure 1.
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3.1. Fluorescent cell trackers
Cell trackers have been successfully used for years in multiple studies, starting from immu-
nology, which intensively utilized flow cytometry techniques [17–19]. Today, there is a broad 
spectrum of commercially available tracking dyes, which simultaneously allow to track cells 
and study proliferation and/or viability. Cell tracking dyes vary widely in their chemistries 
and fluorescence properties but the great majority fall into one of two classes based on their 
mechanism of cell labeling. They are represented by “membrane dyes,” which are highly lipo-
philic dyes that go stably but noncovalently into cell membranes or “protein dyes,” which 
are amino-reactive dyes that form stable covalent bonds with cell proteins [20]. They are safe 
and can be used in viable cells even in the long-term cultures. Big variability allows excitation 
by any available laser and usage in combination with other fluorochromes in multiparameter 
studies. Table 1 presents the tracking dyes currently available for different lasers. These dyes 
can be used separately or combined due to their different excitation signals. It is important 
to mention that due to its nature, the fluorescent signal of labeled population is decreasing, 
depending on the growth rate of cells. So, quickly dividing cells will lose tracing signal faster 
than cells with longer cell cycle. This feature, on the one hand, enables monitoring of cell pro-
liferation rate in co-culture setups but on the other hand limits the time frame within which the 
subpopulation of dye-labeled cells can be distinguished. Figure 2 presents an example of the 
time-course of CMAC fluorescence measured by flow cytometry, when different concentra-
tions of CMAC dye were used. After 72 h, two populations were not clearly separated anymore 
when the lower concentration of CMAC was used. Therefore, also concentration of the dye 
used for labeling of different types of cells should be chosen accordingly to the level of fluores-
cence detected at the end time point of planned experiment and verified in the toxicity assay.
Another strategy to track cells is expression of fluorescent proteins. Green fluorescent protein 
(GFP) has been purified in the 60-ties from Aequorea victoria [21]. This has started a new era 
of studies, in which original or engineered GFP as well as other fluorescent proteins were 
utilized to tag proteins of interest. Today, GFP derivatives, yellow fluorescent protein (YFP) 
and a big family of red fluorescence proteins (RFP), which are derivatives of DsRed isolated 
from Discosoma sp. [22], are commonly used in many different studies. The advantage of this 
strategy is stable fluorescent signal; however, the stable expression of fluorescent proteins has 
some limitations, requires transfection of cells and is connected with the nonphysiological 
Figure 1. Scheme of the cell type separation by fluorescent tracking followed by flow cytometry gating.
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Function Excitation laser [nm] Dye Emission (nm)
Proliferation 405 (violet) CellTrace violet cell proliferation kit 450
Violet proliferation dye 450 450
488 (blue) CFSE 520
EdU proliferation kit (iFluor 488) 520
530 (yellow-green) CellTrace yellow cell proliferation kit 579
560 (yellow) CellTrace yellow cell proliferation kit 579
633/640 (red) CellTrace far red cell proliferation kit 661
Viability 355 (UV) CellTrace calcein blue 425
Hoechst 33258 450
DAPI 470
405 (violet) CellTrace calcein violet 452
SYTOX blue dead cell stain 480
488 (blue) CellTrace calcein green 515
SYTOX green dead cell stain 523
TO-PRO™-1 iodide 530
SYTOX orange dead cell stain 570
Propidium iodide 617
7-AAD (7-aminoactinomycin D) 647
530 (yellow-green) SYTOX orange dead cell stain 570
Propidium iodide 617
7-AAD (7-aminoactinomycin D) 647
560 (yellow) Propidium iodide 617
7-AAD (7-aminoactinomycin D) 647
633/640 (red) TO-PRO™-3 iodide 661
Fixable viability 355 (UV) Live/dead fixable dead cell stain kit (450) 450
405 (violet) Live/dead fixable dead cell stain kit (450) 450
Fixable viability stain 450 450
Fixable viability stain 510 510
Live/dead fixable dead cell stain kit (525) 525
Live/dead fixable dead cell stain kit (575) 575
Fixable viability stain 575 V 575
488 (blue) Fixable viability stain 520 520
Live/dead fixable dead cell stain kit (530) 530
Live/dead fixable dead cell stain kit (585) 585
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overexpression of novel form of protein. On the other hand, the signal from the expressed 
fluorescent protein is relatively stable over time. Thus, this attitude might have advantage 
over cell tracking in case of long-term experiments.
Recently, a highly advanced methodology based on the lentiviral fluorescent genetic barcod-
ing system for flow cytometry-based multiplex cell tracking has been used to follow clonal 
subpopulations in the real time [23]. Cells transduced with the lentiviral vectors are individu-
ally marked by a highly characteristic pattern of insertion sites inherited by all their progeny. 
The system allows creation of 26, 14, or 6 unique labels, and the color-coded populations can 
be tracked for up to 28 days.
Another strategy to perform high-content multiplex analysis is based on the fluorescent cell 
barcoding (FCB) technique [24, 25]. In FCB, each sample is labeled with a unique fluores-
cent signature (barcode), of different fluorescence intensity (due to dilutions) and/or emis-
sion wavelength, mixed together with other samples, then stained with antibodies or probes 
and analyzed by flow cytometry as a single sample. Today, there is a variability of FCB dyes 
Function Excitation laser [nm] Dye Emission (nm)
530 (yellow-green) Fixable viability stain 620 620
560 (yellow) Fixable viability stain 570 570
633/640 (red) Fixable viability stain 660 660
Live/dead fixable dead cell stain kit (660) 660
Fixable viability stain 700 700
Live/dead fixable dead cell stain kit (780) 780
Cell tracking 355 (UV) Hoechst 33342 450
CytoPainter blue cell tracking staining kit 455
CellTracker™ blue CMF2HC 464
CellTracker™ blue CMAC 466
405 (violet) CellTracker™ violet BMQC 516
CytoPainter green cell tracking staining kit 520
488 (blue) CellTracker™ green CMFDA 517
530 (yellow-green) CytoPainter orange cell tracking staining kit 560
560 (yellow) CellTracker™ CM-DiI 570
CellTracker™ orange CMRA 575
CytoPainter red cell tracking staining kit 600
CellTracker™ CMTPX 602
633/640 (red) CellTracker™ deep red 650
CytoPainter deep red cell tracking staining kit 650
Table 1. Tracking dyes used for fluorescent cell staining; function, excitation, and emission spectra as well as full name 
are shown.
Multidimensional Flow Cytometry Techniques for Novel Highly Informative Assays24
which can be utilized, such as CBD500, Pacific Orange NHS ester, DyLight 350 NHS ester, 
and DyLight 800 NHS ester, Pacific Blue dyes, Alexa dyes, eFluor, and others. Using this tech-
nique allows to perform multiplate assays in relatively short time and with economical use of 
reagents, as mixing sample prior to staining, antibody consumption is reduced 10- to 100-fold. 
Importantly, either viable or fixed samples can be barcoded, thus giving broad possibilities 
to combine FCB with other multiparameter protocols. Such strategy can be used to analyze 
samples under treatments, co-cultured, or stimulated with different agents. FCB has been 
successfully utilized for different studies, including drug screening and cell signaling profil-
ing studies [26], intracellular cytokine production [27], immunophenotyping [28], and others.
3.2. Cell proliferation dyes
Quantitative assessment of proliferation is an important parameter in leukemia and other can-
cer studies. Especially, when co-culture with stroma provides protective signaling, proliferation 
is analyzed as one of the major parameters to estimate cytostatic effects. Moreover, proliferation 
dyes can also be utilized to fluorescently track cells in co-culture. So, in addition to detection 
and quantifying cell divisions, these dyes can be used to distinguish one type of cells from the 
other. The measurement, independently on the tracking dye used, relies on the same mecha-
nism, namely permanent labeling of cells without affecting morphology or physiology to trace 
generations or divisions in vivo or in vitro. Dilutions of the dye equally distributed to daughter 
cells as a result of cell divisions can be measured by flow cytometry [17, 20]. The scheme of CFSE 
dilution with each cell division and flow cytometry measurement is presented in Figure 3.
For many years, CFSE dye (carboxyfluorescein succinimidyl ester) was a gold standard for 
tracking cell divisions [29]; however, today there is a variety of tracking dyes allowing to 
measure the proliferation index. Proliferation dyes are available for the UV, violet, blue, yel-
low, and red lasers, giving more flexibility in multiplexed experiments [29, 30] (see Table 1, 
Proliferation). Compared to the classical CFSE, modern proliferation trackers are less cytotoxic 
Figure 2. The time-course of CMAC fluorescence measured by flow cytometry upon conditions when different 
concentrations (10 and 25 μM) of CMAC dye were used. CMAC-positive (CMAC+, blue) subpopulation is gated. Green 
subpopulation represents CMAC-negative cells in co-culture.
Insight into the Leukemia Microenvironment and Cell-cell Interactions Using Flow Cytometry
http://dx.doi.org/10.5772/intechopen.76481
25
and more stable. Importantly, what has been already mentioned above, decrease of the fluo-
rescence signal resulting from dye dilution with every division has to be considered when 
tracking cells with proliferation dyes.
In our studies, in which GFP-expressing CML cells have been co-cultured with stroma fibro-
blasts labeled with CMAC dye, tracking of subpopulations has been combined with analysis 
of proliferation (Figure 4). To do so, subpopulations have been gated based on the fluorescent 
signal of the cell tracker, either GFP (A) or CMAC (B), followed by separate analysis of cell 
divisions in each subpopulation. Such strategy allowed to investigate the impact of co-culture 
conditions on the proliferation index of either leukemia or stromal cells. This protocols can 
also be utilized in co-cultures under treatment with anticancer drugs to verify the protec-
tive effect of stroma. Similar strategy has been used to investigate interactions of lympho-
cytes with mesenchymal stem cells [31] as well as in the co-cultures of healthy or malign 
breast tissue-derived stromal cells with human breast adenocarcinoma cell line MCF-7 [32]. 
Altogether, proliferation dyes represent a very potent group of tracking dyes analyzed with a 
broad range of available lasers and cytometers.
3.3. Multiparameter studies
Modern flow cytometry, due to development of multiple laser systems, provides possibil-
ity for polychromatic analysis of many parameters in single cells. The key to success, par-
ticularly in the studies, in which multiple dyes are used to track different types of cell, is 
therefore to understand the critical issues enabling optimal use of different tracking dyes. 
It has to be noticed that some limitations appear when using tracking dyes in co-culture 
experiments. Each class of commercially available cell trackers—lipophilic “membrane” 
dyes and amino-reactive “protein” dyes possess advantages and limitations. Thus, there is 
a need for optimization of different proliferation tracking dyes especially when combined 
together [33]. Recently, a novel edition of protocols to study cell proliferation by dye dilu-
tion, alone or in combination with other methods, has been published [34]. The authors dis-
cuss currently available tracking dyes, with suppliers and new spectral properties, as well 
as describe evaluations to be performed when selecting one for use in multicolor prolifera-
tion monitoring. The protocols presented by the authors address the critical issues related 
Figure 3. The scheme of tracking cells with proliferation dye. Dilution of CFSE with cell divisions (left panel) and CFSE 
detection by flow cytometry (right panel) are shown.
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to suboptimal tracking combinations, reproducible labeling, combining of cell tracking 
dyes with fluorescent antibodies staining and others. Briefly, the recommendations include 
evaluating the dye’s spectral profile and available cytometers/lasers to optimize compat-
ibility with other fluorochromes and to minimize compensation problems, evaluating the 
effect of labeling on cell growth rate, testing cell divisions and dye dilutions to determine 
the maximum number of generations to be included when using dye dilution profiles, and 
verifying that relevant cell functions remain unaltered by tracking dye labeling.
As proliferation is tracked in living cells, it enables to combine analysis of cell proliferation 
with other live-cell applications, such as immunophenotyping, cell sorting, cell cycle analy-
sis, mitochondrial potential, ROS studies, and others. This possibility has been utilized, for 
example, in the studies in which myelin-phagocytosing macrophages were co-cultured with 
CFSE-labeled T lymphocytes followed by analysis of surface receptors and role of nitric oxide 
[35]. In other studies, cell tracker has been used to investigate immune cells proliferation and 
cytotoxicity [36].
Another group of trackers is represented by the fixable viability dyes, enabling the post-fixa-
tion discrimination of dead cells, which lost plasma membrane integrity before fixation (see 
Table 1, Viability). This gives a novel opportunity to combine them with staining procedures 
which require fixation. Thus, analysis of internal targets, like as intracellular protein levels 
or γH2AX, within the population of cells which was alive prior fixation, was possible. In our 
Figure 4. Analysis of cell proliferation estimated upon tracking with CMAC, combined with cell-type gating in co-culture 
of leukemia and stromal cells. (A) Leukemia cells expressed GFP protein (GFP+) and (B) stromal cells were tracked with 
CMAC (CMAC+). Labeling with CMAC allowed for cell-type gating and simultaneous analysis of cell divisions. CMAC 
was detected in the APC channel; histograms show CMAC dilution at different time points of co-culture.
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studies, we have combined cell tracking with GFP expression together with analysis of apop-
tosis by fixable viability dye and detection of intracellular level of Grp78 protein (Figure 5). 
Cells were co-cultured and the subpopulation expressing high level of GFP (GFP+) was gated 
and further analyzed. Additionally, as cells were treated with anti-leukemia drug, this proce-
dure enabled to estimate sensitivity to treatment by detection of dead cells.
4. Application of flow cytometry in the studies of cell-cell cross talk 
by extracellular vesicles
4.1. Extracellular vesicles
In recent years, extracellular vesicles (EVs) have emerged as an important mean of intercel-
lular communication, both in physiological conditions and in disease. They seem to play a 
crucial role in the cell-cell communication between cancer cells and the neighboring cells and 
they have been shown to be important for the development of cancer [37, 38]. Extracellular 
vesicles are released by most cell types and contain lipids, proteins, and different nucleic 
acids—mRNAs, ncRNAs (including miRNAs), and fragments of DNA. EVs are classified 
depending on their origin: released from multivesicular bodies (exosomes, 30–100 nm), shed 
from plasma membrane (microvesicles, usually 50–500 nm), or formed during apoptosis 
(apoptotic bodies, about 1 μm) [39, 40]. EVs can influence targeted cells both locally and in 
distant tissues. They regulate multiple biological processes, such as cell differentiation, tissue 
homeostasis, immune response, and cell signaling, and can contribute to disease progression, 
for example, by affecting tumor microenvironment [41]. Recently, the role of EVs in tissue 
repair, immunotherapy, and drug delivery has also been evaluated.
Extracellular vesicles play a significant role in pathology of hematological malignancies, includ-
ing chronic myeloid leukemia (CML) [42]. It has been demonstrated that exosomes produced by 
Figure 5. Combination of cell tracking by expression of GFP protein (GFP+, green), with analysis of apoptosis by using 
fixable viability dye and estimation of intracellular level of Grp78 protein (red histograms). Subpopulation expressing 
high level of GFP was gated (GFP+) and further analyzed. Cells were untreated (control) or treated with antileukemic 
drug for 24 h.
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CML cells support leukemic cell growth and survival in an autocrine manner, both in vitro and 
in vivo [43]. Moreover, factors facilitating leukemic transformation have been identified within 
vesicles released by leukemia cells [44]. Extracellular vesicles not only directly supported leuke-
mia cell growth but also potently modified components of CML microenvironment to further 
promote leukemia progression. CML-derived exosomes activated EGFR signaling in stromal 
cells, which led to IL-8 production by stroma bone marrow fibroblasts and which in turn stimu-
lated leukemia cell adhesion to stromal cells [45, 46]. CML exosomes have been widely studied 
in terms of their influence on neovascularization process, which has previously been shown 
to support progression of leukemia [47]. Our own unpublished data suggest that extracellular 
vesicles released by murine BCR-ABL-expressing progenitor cells may also influence function 
of cells in distant tissues. Altogether, this supports the notion that leukemic EVs constitute an 
important mechanism of disease progression both by direct influence on CML cells and by indi-
rect modification of leukemic niche components and immune cells. Moreover, EVs components, 
such as proteins and microRNAs, have recently become of interest as biomarkers in hematologi-
cal malignancies [42, 48, 49]. Thus, analysis of EVs number, size, and composition may soon be 
used to diagnose, stage, and even analyze relapse of hematological malignancies in the clinical 
setting.
4.2. Analysis of EVs uptake and binding by flow cytometry
Multiple studies underline functional relevance of different extracellular vesicles. Thus, a sig-
nificant aspect of research is analysis of fluorescently labeled EVs uptake or binding to differ-
ent cells, both in in vitro and in vivo experiments. It allows to confirm biological relevance of 
experiments and exclusion of indirect effects on target cells. Different analytical techniques 
are used to study extracellular vesicles, as there is no one single method which can be pro-
posed to analyze these particles [50]. Confocal microscopy is widely used to analyze EVs 
uptake by cells [51]. However, the flow cytometry provides a very good and fast method for 
quantification of EVs uptake or binding to cells.
Flow cytometry allows to quickly assess if association of EVs with target cells is dose- and time-
dependent. This may incline biologically active doses of EVs and thus help choose appropri-
ate amounts of EVs for further functional studies. Multicolor flow cytometry allows to monitor 
association of EVs to different subpopulations of cells, especially in vivo or in ex vivo cultures of, 
for example, immune cells. This is doable if a combination of fluorescent EVs labeling is used 
in parallel with staining of protein markers of subpopulations with fluorochrome-conjugated 
antibodies. Moreover, flow cytometry analysis enables correlation of EVs uptake with various 
biological parameters, such as cell viability, apoptosis, proliferation, and expression of signaling 
molecules. Such approach allows more precise and direct observation of functional effects of EVs. 
On the other hand, opposed to confocal microscopy, flow cytometry does not distinguish between 
uptake and binding of extracellular vesicles to target cells, but rather gives information on associa-
tion of EVs with target cells. Such information may be relevant in terms of mechanism of influence 
on target cells, as solely binding to surface of target cell suggests regulation through mediators 
(mostly proteins) on EVs surface rather than by, for example, non-coding RNAs in the lumen.
Various methods and reagents may be used to fluorescently label extracellular vesicles for 
analysis using flow cytometry (Table 2). EVs staining can either lead to labeling of all types of 
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vesicles or any of the specific populations, like exosomes or microvesicles. To stain EVs lumen, 
widely used dyes such as CFSE and CalceinAM may be used. Those dyes in non-fluorescent 
form passively enter EVs and due to esterase activity in the EV lumen are transformed into 
fluorescent molecules. Gray et al. demonstrated that CalceinAM stains only intact EVs, which 
may be advantageous for its use in both EVs uptake studies and direct flow cytometry of EVs 
[52]. CFSE staining was applied to quantitatively show differential association of cancer EVs 
with myeloid cells depending on their differentiation into various stages of monocyte and 
dendritic cell development [53]. In our experiments, we have used CFSE labeling to study the 
dose-dependent uptake of EVs released by murine BCR-ABL-expressing cells by thymocytes 
(Figure 6). It is clearly visible that increasing amounts of fluorescently labeled EVs correlate 
with increased fluorescence of CFSE signal detected in acceptor thymocytes.
Membrane staining is also widely used to label EVs with the use of dyes such as PKH67, 
PKH26, DiD, Dil, and DiO. They allow a wider choice of fluorescence spectra but, as they 
are lipophilic, can form various aggregates and micelles. Thus, in this case, EVs need to be 
carefully washed to avoid adding unbound dye which may nonspecifically label cells. PKH67 
Figure 6. CFSE labeling to study uptake of EVs. Leukemia-released EVs were labeled with CFSE and different amounts 
of EVs were added to thymocytes. Fluorescence of CFSE in thymocytes was detected by flow cytometry in FITC channel.
Function Excitation laser (nm) Dye Emission (nm)
Lumen labeling 488 (blue) CFDA-SE (CFSE) 517
CalceinAM 515
Membrane labeling 488 (blue) PKH67 504
DiO 501
560 (yellow) PKH26 567
Dil 565
633/640 (red) DiD 665
Table 2. Fluorescent dyes used to fluorescently label extracellular vesicles for analysis by flow cytometry; function, 
excitation, and emission spectra as well as full name are shown.
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was used for EVs labeling to track time-dependent uptake of mantle cell lymphoma-derived 
exosomes by different immune cells and cell lines and to investigate their possible therapeu-
tic potential. Lai et al. took another approach on staining of EV membrane by fusing GFP at 
N-terminus with palmitoylation signal and thus directing it to plasma and EV membrane. 
This enabled more specific staining than with the use of PKH67 dye. Additionally, it allows 
effective in vivo tracking of EVs released by tumors [51]. Furthermore, fusion of specific 
EV-enriched proteins (such as tetraspanins—CD9, CD63, CD81; ESCRT proteins—Tsg101; 
proteins widely expressed on cells producing EVs—e.g. HLA proteins) with GFP/RFP or 
other fluorescent proteins can be applied. CD63-GFP and CD81-GFP have already been used 
by different groups to track exchange of EVs using flow cytometry [54].
4.3. Flow cytometry analysis of extracellular vesicles
Flow cytometry has emerged as one of the tools for analysis of extracellular vesicles and their 
composition. As detection limit of conventional flow cytometers is around 500 nm, bead cap-
ture of EVs has been used to facilitate, for example, analysis of proteins expressed on their sur-
face. However, direct flow cytometry of extracellular vesicles has also been widely performed 
[55]. As light scatter triggering itself is not sufficient to distinguish nanoscale vesicles, fluo-
rescence triggering has been used to directly identify EVs on flow cytometers. Commercially 
available flow cytometer (BD Influx) has been adapted for high-throughput analysis of fluo-
rescently labeled vesicles. PKH67 staining of EVs allowed fluorescence-based thresholding of 
events, and by modifying cytometer elements, the authors were also able to observe size dis-
tribution of exosomes in the FSC channel. The described technique allowed to identify mol-
ecules expressed on the surface of EVs [56] and then apply the method to perform quantitative 
and qualitative analyses of dendritic cell-released EVs upon different stimulations and culture 
conditions [57]. Direct flow cytometry of fluorescently labeled EVs using conventional flow 
cytometers has been applied to study mesenchymal stromal cell markers (CD90, CD44, CD73) 
on EVs released by HS-5 and K562 cells as well as to analyze surface molecules expressed on 
microvesicles isolated from patient sera with hematological tumors (CD20, CD38, CD30) [48].
However, direct flow cytometry of EVs needs to be used cautiously, as different sample 
parameters and cytometer settings may affect measurements. It was demonstrated that due 
to high concentration of very small molecules in suspension, the measurement may not be 
precise, due to analysis of multiple events as one. Flow cytometry is emerging as a tool for 
direct analysis of EVs and their surface markers, allowing fast and precise measurements. 
Various aspects of EVs analysis by FACS are demonstrated in a special issue of Cytometry 
Part A Journal “Measurement of Extracellular Vesicles and Other Submicron Size Particles by 
Flow Cytometry” [58]. It is noteworthy that due to small size of EVs precise fluorescent label-
ing needs to be applied and conventional flow cytometer settings need to be cautiously opti-
mized, for example, by using fluorescent beads of different sizes (e.g. 200 and 100 nm beads).
4.4. Fluorescent tracking and flow cytometry analysis of direct, intercellular transfer 
of vesicular cargo
Recently, a novel way of intercellular communication has been described. This is mediated 
by the long intercellular connections called tunneling nanotubes (TNTs), which link two cells 
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and enable long-range, direct communication between distant cells [59]. Formation of this 
structure has been observed between different types of cells by different groups including 
ours [60–63] and Figure 7A and B. They have been shown to mediate the cell-to-cell transfer of 
vesicles, organelles, electrical stimuli, and small molecules [64–66]. The proposed functions of 
TNTs and mechanism are still not well understood; however, there is growing evidence that 
cell-cell communication via TNTs might play an important role in the cancerogenesis. They 
are actively formed between leukemia cells and bone marrow-derived mesenchymal stromal 
cells to promote viability and chemoresistance of leukemia cells [67].
Vesicular cargo can be actively transferred by TNTs between two distinct cells. For now, the 
flow cytometry is one of the best methodologies to track and analyze cells, which obtained 
vesicles from donor cells [68–70]. For this, methods to label vesicles has been adapted (Table 2) 
and combined with cell type tracking to distinguish donor and acceptor cells. First, vesicles 
in donor cells are labeled with lipophilic dyes, such as DiD, DiO, and others, and mixed with 
acceptor cell population. Flow cytometry allows to separate both subpopulations—positive 
population of donor cells (DiD+) and negative population of acceptor cells (DiD-), together 
with additional combination with cell-type tracking with GFP (Figure 7C, time 0 h). After 
Figure 7. (A) Overlay of confocal images presenting formation of tunneling nanotube (TNT); actin—green, microtubules—red, 
nuclei—blue); (B) SEM micrograph of a TNT formed between two distant cells; (C) flow cytometry dot plots showing the gating 
strategy to separate the donor and acceptor populations upon labeling of vesicular cargo by DiD (0 h), the uptake of vesicular 
cargo visible as appearance of DiD+ acceptor cells (24 h), and the absence of uptake upon donor and acceptor populations 
physical separation in control experiment (24 h: transwell system).
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incubation, the fluorescence signal appears in the acceptor cells (GFP+, DiD+), indicating 
uptake of the vesicular cargo transferred from donor cells (Figure 7C, time 24 h). To confirm 
that vesicles were transferred by direct cell-cell contact, not secreted into the medium, the 
trans-well control has been performed. In this case, the vesicle uptake has not been observed 
(Figure 7C, transwell). Such methodology has been already successfully used in different 
cellular systems [60, 69, 71] to analyze direct transfer of vesicles between cells.
5. Interactions of leukemia cells with immunosuppressive 
regulatory T cells
Immune responses against hematological cancers are less characterized than those against 
solid tumors. Among them, chronic myeloid leukemia (CML) is not an exception [72]. Little is 
known about mechanisms of innate and acquired immunity exerted against CML. Although, the 
involvement of CD4+ and CD8+ T cell as well as NK cells and humoral response in the immunity 
against CML is widely accepted. Recently, CML-specific antigens exerting cellular and humoral 
response have been identified [73, 74]. The growing body of evidences is pointing the role of 
cytotoxic CD8+ T cell as a central player in the anti-CML response. [3, 8] Moreover, CML is 
considered as one of the diseases which are most sensitive to immunological manipulation [75].
Analysis of blood of untreated patients diagnosed with CML reveals decreased number of 
NK-cells, which are antitumor effector cells [76]. Moreover, the increased number of inhibitory 
cells such as T regulatory (T
reg
) cells and myeloid-derived suppressor cells were present [77]. 
Also, it has been shown that CML cells (including CD34+ leukemia stem cells) express pro-
grammed death receptor ligand 1 (PD-L1). Binding of PD-L1 to the PD-1 receptor expressed 
on T cells suppresses their effector function.
Immune evasion is a major obstacle for effective anticancer therapy. T regulatory (T
reg
) cells are 
recognized as one of the most promising targets for therapy, which could reverse the unrespon-
siveness of the immune system during malignancy [73]. T
reg
 cells are essential for maintain-
ing homeostasis of the immune system during the steady state and inflammation. The balance 
between immune activation and tolerance mediated by T
reg
 cells is crucial for maintaining proper 
responses. The suppression exerted by T
reg
 cells to different types of immune cells has been 
extensively studied. Activity of T
reg
 cells is beneficial for maintaining self-tolerance, during reso-
lution of inflammation, and for limiting inadequate immune responses. However, their ability 
to suppress different types of immune cells may also restrain beneficial responses by limiting 
the anti-tumor immunity. T
reg
 cells constitute a major component of the tumor-infiltrating lym-
phocytes in human malignancies as well as in mouse experimental models of cancer. Moreover, 
the increased number of T
reg
 cells among tumor-infiltrating lymphocytes correlates with a poor 
prognosis and an increased risk of recurrence in majority of solid tumors. In CML patients, the 
increased number of T
reg
 cells is linked to limited anti-tumor immune effector responses [78, 79]. 
Data suggest that a balance between the effector and suppressor arms of the immune system 
could be important in mediating a successful and treatment-free remission (TFR). However, a 
major goal in CML treatment is to identify the uppermost target to maximize beneficial immune 
response and promote TFR success [74]. In this context, the study of T regulatory cells is critical. 
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To explore the CML-derived extracellular vesicles impact on T regulatory cell development and 
activity, we adjust two in vitro assays, both based on the flow cytometry.
5.1. Flow cytometry analysis of T regulatory (T
reg
) cells differentiation and function
To study the effect of CML extracellular vesicles on the differentiation of thymic regulatory T 
cells (tT
reg
), we have employed a previously described in vitro assay of tT
reg
 differentiation on 
JAWS II immature dendritic cells [80]. Briefly, during the step of preactivation of thymocytes on 
αCD3-coated plates, we added extracellular vesicles to allow their uptake or binding solely by 
thymocytes. Thymocytes were additionally stained with a violet proliferation dye 450, which 
would allow to track their proliferation and distinguish them from JAWS II cells. After 24 h of 
preactivation, thymocytes were washed and co-cultured with JAWS II cells. Afterwards, tT
reg
 
differentiation using multicolor flow cytometry was analyzed. This analysis allowed to track 
viability, proliferation (Figure 8A), differentiation of tT
reg
, as well as their phenotype (Figure 8B). 
Extracellular vesicles can also potentially influence suppressive activity of mature, already dif-
ferentiated tT
reg
. To study this phenomenon, we sorted tT
reg
 and cultured them, first with CML 
extracellular vesicles for 24 h and afterwards with conventional T cells (responder cells) stimu-
lated for proliferation, to observe differences in suppressive activity manifested by decreased 
Figure 8. Flow cytometry analysis of T regulatory (T
reg
) cells differentiation and function. (A) Analysis of cell viability 
and proliferation (AmCyan channel—fixable viability stain eFluor 506, V450—violet proliferation dye 450). V450 
staining allows to track thymocyte proliferation and distinguish them from JAWS II cells (V450-). (B) Identification of T 
regulatory cells by sequential gating and analysis of CTLA-4 expression. (C) CFSE staining allows to track proliferation 
of responder cells in an in vitro suppression test. An example of combination with CD4-APC staining, which helps 
eliminate remaining Treg cells (CFSE-, CD4+) in analysis, is presented.
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proliferation. Labeling of responder cells with CFSE allowed to track their proliferation after co-
culture with tT
reg
, which have been preincubated with either CML-derived or control extracellu-
lar vesicles. This in turn allowed to assess differences in tT
reg
 suppressive activity due to influence 
of EVs. Combination with additional staining of surface receptors such as CD4 or CD8 enabled to 
distinguish between suppression towards helper (CD4+) or cytotoxic (CD8+) T cells (Figure 8C).
6. Summary
Many studies already confirmed that leukemia cells behave differently whether they are cul-
tured alone or in co-culture with stromal cells. This mimics some elements of the bone mar-
row microenvironment and represents more physiological conditions. Also, the cross talk 
between leukemia and immune cells is an example showing importance of the interactions 
within the leukemia microenvironment. Thus, in our opinion, analysis of cell signaling in the 
co-culture conditions is highly informative and might have some therapeutic implications.
Studies of leukemia cells in vitro/ex vivo, including analysis of primary cells and stem/progeni-
tor subpopulations, represent an important step in development of novel therapeutic strate-
gies. Different parameters, such as viability, proliferation, DNA damage, clonogenic potential, 
and others, are investigated after treatment with drugs or drug candidates. Pretreatment with 
investigated drugs can also be followed by mice Xenograft in vivo studies to investigate their 
therapeutic potential. All these studies are critically important as a first step in analysis of 
potential therapeutic strategies.
Nevertheless, we propose that in the next step or simultaneously, some of these studies might 
be performed also upon co-culture conditions to add an essential element of the cross-talk 
with stroma components, which normally exist in vivo. These conditions allow to verify 
whether the treatment is still effective even upon protective impact of stroma. This fulfills, at 
least partially, the big gap between in vitro experiments and in vivo conditions.
In this chapter, we described and discussed flow cytometry applications, which can be used to 
perform co-culture studies to analyze some signaling elements within the leukemia microenvi-
ronment. This strategy enables to distinguish between the cell types and to investigate the cross 
talk between cancer and surrounding cells, signaling pathways regulated by the cell-cell interac-
tions, as well as sensitivity to treatment with anticancer drugs in the stroma-mimicking condi-
tions. Utilizing modern flow cytometry and a broad spectrum of currently available dyes/trackers 
allows to perform highly informative studies not only because of the use of multiparameter 
cytometry but also because of more complex cellular context, which is taken under consideration. 
Moreover, even if the described flow cytometry applications rely on the leukemia microenviron-
ment studies, they are uniform and can be broadly applied into another biological context.
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